Protective behavior and West Nile virus risk

Emerging Infectious Diseases

Volumn 11, Issue 9, 2005, Pages 1433-1436

  Loeb, Mark ^a   Elliott, Susan J ^a   Gibson, Brian ^b   Fearon, Margaret ^b   Nosal, Robert ^c   Drebot, Michael ^d   D'Cuhna, Colin ^b   Harrington, Daniel ^a   Smith, Stephanie ^a   George, Pauline ^c   Eyles, John ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

^c Halton Region Health Department   (Canada)

^d HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANADA; EPIDEMIC; FEMALE; HOUSEHOLD; HUMAN; INCIDENCE; INFECTION RISK; MALE; NONHUMAN; REVIEW; RISK FACTOR; VIRUS ENCEPHALITIS; VIRUS MENINGITIS; WEST NILE FLAVIVIRUS;

EID: 23944443230     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1109.041184     Document Type: Review

References (13)

1. Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, Cooper MJ, et al. Epidemic West Nile encephalitis. New York, 1999: results of a house-hold based seroepidemiologic study. Lancet. 2001;358:261-4.
2. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807-14.
3. Beaty BJ, Calisher CH, Shope RS. Arboviruses. In: Schmidt NJ, Emmons RW, editors. Diagnostic procedures for viral, rickettsial and chlamydial infections. 6th ed. Washington: American Public Health Association; 1989. p. 797-856.
4. Ford-Jones EL, Fearon M, Leber C, Dwight P, Myszak M, Cole B, et al. Human surveillance for West Nile virus infection in Ontario in 2000. CMAJ. 2002;166:29-35.
5. Han LL, Popovici F, Alexander JP Jr, Laurentia V, Tengelsen LA, Cernescu C, et al. Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996. J Infect Dis. 1999;179:230-3.
6. Tsai TF, Popvici F, Cernescu C, Campbell GL, Nedelcu NI. West Nile encephalitis epidemic in southeastern Romania. Lancet. 1998;352:767-71.
7. Centers for Disease Control and Prevention. Serosurveys for West Nile virus infection: New York and Connecticut counties, 2000. MMWR Morb Mortal Wkly Rep. 2001;50:37-9.
8. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, van Gerpen JA, et al. Neurological manifestations and outcome of West Nile virus infection. JAMA. 2003;290:511-5.
9. Pepperell C, Rau N, Krajden S, Kern R, Humar A, Mederski B, et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ. 2003;168:1399-405.
10. Weiss D, Carr D, Kellachan J, Tan C, Phillips M, Bresnitz E, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis. 2001;7:654-8.
11. Emig M, Apple DJ. Severe West Nile virus disease in healthy adults. Clin Infect Dis. 2004;38:289-92.
12. Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, Austin CC, et al. Clinical characteristics and functional outcomes of West Nile fever. Ann Intern Med. 2004;141:360-5.
13. Klee AL, Maidin B, Edwin B, Poshni I, Mostashari F, Fine A, et al. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis. 2004;10:1405-11.